Ashland Global Holdings Inc. provides specialty chemical solutions worldwide. The company's Specialty Ingredients segment offers products, technologies, and resources for solving formulation and product-performance challenges. It provides solutions using natural, synthetic, and semisynthetic polymers derived from cellulose ethers, vinyl pyrrolidones, acrylic polymers, polyester and polyurethane-based adhesives, and plant and seed extracts. This segment offers its solutions for the pharmaceutical companies; makers of personal care products, food, and beverages; makers of nutraceuticals and supplements; manufacturers of paint, coatings, and construction materials; packaging and converting markets; and oilfield service companies. Its Intermediates and Solvents produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone that are used as chemical intermediates in the production of engineering polymers and polyurethanes, as well as specialty process solvents used in electronics, pharmaceuticals, water filtration membranes, and others. The company was formerly known as Ashland Inc. and changed its name to Ashland Global Holdings Inc. in September 2016. Ashland Global Holdings Inc. was founded in 1924 and is based in Wilmington, Delaware.
IPO Year:
Exchange: NYSE
Website: ashland.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/6/2026 | $75.00 | Neutral → Buy | Seaport Research Partners |
| 12/15/2025 | $71.00 | Market Perform → Outperform | BMO Capital Markets |
| 9/8/2025 | $60.00 | Equal-Weight | Morgan Stanley |
| 5/1/2025 | Overweight → Equal Weight | Wells Fargo | |
| 3/26/2025 | $68.00 → $71.00 | Neutral → Overweight | Analyst |
| 3/5/2025 | Buy → Neutral | Seaport Research Partners | |
| 8/8/2024 | $90.00 → $89.00 | Underweight → Neutral | JP Morgan |
| 4/11/2024 | $100.00 → $112.00 | Equal Weight → Overweight | Wells Fargo |
| 3/14/2024 | $100.00 → $126.00 | Hold → Buy | Jefferies |
| 3/1/2024 | $108.00 | Outperform | Wolfe Research |
Fastest customizable press release news feed in the world
WILMINGTON, Del., May 18, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) is announcing the appointment of Bertrand Loy to its board of directors, effective May 15, 2026. Loy currently serves as a director and the executive chair of Entegris Inc. (NASDAQ:ENTG), a leading supplier of advanced materials and process solutions for the semiconductor and high-technology industries and previously served as Entegris' president and chief executive officer. He will serve on the board's audit and governance and nominating committees, also effective as of May 15, 2026. With the addition of Loy and in anticipation of potential director retirements under the board's retirement and resignation policy,
WILMINGTON, Del., May 05, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock which represents a 1.2 percent increase from the previous quarter. The dividend will be payable on June 15, 2026, to stockholders of record at the close of business on June 1, 2026. As of April 30, 2026, there were 45,788,007 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of co
Sales of $482 million, up one percent from the prior-year quarterIncome from continuing operations of $15 million, or $0.32 per diluted shareAdjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $42 million, or $0.91 per diluted shareNet income of $16 million, or $0.34 per diluted shareAdjusted EBITDA of $98 million, down nine percent from the prior-year quarter, primarily reflecting temporary operational impacts from the Calvert City startup delay, Hopewell productivity challenges, and weather-related disruptions in the second quarterCash flows provided by operating activities of $50 million; Ongoing Free Cash Flow2 of $29 millionUpdating full‑year fiscal
WILMINGTON, Del., April 15, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced plans to issue its second-quarter fiscal 2026 earnings release at approximately 5 p.m. ET on Tuesday, April 28, 2026. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Wednesday, April 29. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chair, and chief executive officerWilliam Whitaker, senior vice president, and chief fi
Wilmington, Del., March 23, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) is implementing pricing actions across its Life Sciences, Intermediates, Personal Care and Specialty Additives product portfolios globally in response to continued volatility in energy markets, raw material costs and logistics conditions stemming from the conflict in the Middle East. The company is taking proactive actions across procurement, supply chain and operations to actively manage costs where possible, while adjusting pricing to maintain reliable supply to customers under current market conditions. Pricing actions will vary by product and region, reflecting local market dynamics, contractual terms and in
WILMINGTON, Del., March 17, 2026 (GLOBE NEWSWIRE) -- William C. Whitaker, senior vice president and chief financial officer, Ashland (NYSE:ASH), will participate in a fireside chat at the Gabelli Funds' 17th Annual Specialty Chemicals Symposium on Thursday, March 19, 2026, at 1:30 p.m. ET. Whitaker will also host one‑on‑one meetings with institutional investors throughout the day. The symposium will feature discussions with leading companies and organizations across the specialty chemicals ecosystem, with an emphasis on industry dynamics, current trends, business fundamentals, and specialty chemicals investing. Investment professionals and individual investors interested in the specialt
GREENWICH, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 17th Annual Specialty Chemicals Symposium in Midtown Manhattan, New York City on Thursday, March 19, 2026. The event will feature discussions with leading companies and organizations across the specialty chemicals ecosystem, with an emphasis on industry dynamics, current trends, and business fundamentals, as well as Specialty Chemicals investing. Attendees will also have the opportunity to participate in one-on-one meetings with management teams, available upon request. For those who cannot attend in person, access to the symposium will be available via webcast. Investors should contact their Gabelli relations
WILMINGTON, Del., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Ashland announces the United States Environmental Protection Agency (EPA) has officially posted and approved its petition under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) for agrimer™ eco-coat polymer seed coating for crop care. This innovative ingredient is based on the company's patented Transformed Vegetable Oils (TVO) technology. Approval means the ingredient can now be used in all food and non‑food pesticide formulations under regulation 40 CFR 180.960. "We are pleased with the U.S. EPA posting of Ashland's latest crop care chemistry and are excited for the new opportunities this creates for collaboration with o
Sales of $386 million, down five percent from the prior-year quarterPreviously announced Avoca divestiture reduced overall sales by approximately $10 million or two percent versus the prior-year quarter; excluding the Avoca divestiture, sales declined three percentLoss from continuing operations of $14 million, or $(0.30) per diluted shareAdjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $12 million, or $0.26 per diluted shareNet loss of $12 million, or $(0.26) per diluted shareAdjusted EBITDA of $58 million, down five percent from the prior-year quarter, with the Avoca divestiture contributing to a two percent or $1 million decline; excluding the Avoca
Expanding access in EMEA markets to meet rising demand for functional ingredients and drive innovation in food and beverage applications ESSEN, Germany, Jan. 27, 2026 /PRNewswire/ -- Univar Solutions B.V., a subsidiary of Univar Solutions LLC ("Univar Solutions" or "The Company"), a leading global solutions provider of specialty ingredients and chemicals, today announced an exclusive distribution partnership between their Foodology by Univar Solutions business and Ashland Inc. (NYSE:ASH). Ashland is a global, consumer-focused additives and specialty ingredients company recognized for its leading cellulose ether derivatives and polyvinylpolypyrrolidone (PVPP). Beginning January 1, 2026, this
8-K - ASHLAND INC. (0001674862) (Filer)
8-K - ASHLAND INC. (0001674862) (Filer)
SCHEDULE 13D/A - ASHLAND INC. (0001674862) (Subject)
SCHEDULE 13D/A - ASHLAND INC. (0001674862) (Subject)
SCHEDULE 13D/A - ASHLAND INC. (0001674862) (Subject)
10-Q - ASHLAND INC. (0001674862) (Filer)
8-K - ASHLAND INC. (0001674862) (Filer)
SCHEDULE 13G - ASHLAND INC. (0001674862) (Subject)
SCHEDULE 13G/A - ASHLAND INC. (0001674862) (Subject)
SCHEDULE 13G/A - ASHLAND INC. (0001674862) (Subject)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Seaport Research Partners upgraded Ashland from Neutral to Buy and set a new price target of $75.00
BMO Capital Markets upgraded Ashland from Market Perform to Outperform and set a new price target of $71.00
Morgan Stanley initiated coverage of Ashland with a rating of Equal-Weight and set a new price target of $60.00
Wells Fargo downgraded Ashland from Overweight to Equal Weight
Analyst upgraded Ashland from Neutral to Overweight and set a new price target of $71.00 from $68.00 previously
Seaport Research Partners downgraded Ashland from Buy to Neutral
JP Morgan upgraded Ashland from Underweight to Neutral and set a new price target of $89.00 from $90.00 previously
Wells Fargo upgraded Ashland from Equal Weight to Overweight and set a new price target of $112.00 from $100.00 previously
Jefferies upgraded Ashland from Hold to Buy and set a new price target of $126.00 from $100.00 previously
Wolfe Research initiated coverage of Ashland with a rating of Outperform and set a new price target of $108.00
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - ASHLAND INC. (0001674862) (Issuer)
3 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - ASHLAND INC. (0001674862) (Issuer)
4 - ASHLAND INC. (0001674862) (Issuer)
Live Leadership Updates
WILMINGTON, Del., May 18, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) is announcing the appointment of Bertrand Loy to its board of directors, effective May 15, 2026. Loy currently serves as a director and the executive chair of Entegris Inc. (NASDAQ:ENTG), a leading supplier of advanced materials and process solutions for the semiconductor and high-technology industries and previously served as Entegris' president and chief executive officer. He will serve on the board's audit and governance and nominating committees, also effective as of May 15, 2026. With the addition of Loy and in anticipation of potential director retirements under the board's retirement and resignation policy,
WILMINGTON, Del., May 05, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) announced today that Kevin Willis, senior vice president and chief financial officer, has decided to leave Ashland to pursue another opportunity. His last day with the company will be May 16, 2025. Willis joined Ashland in 1987 as an associate auditor in the internal audit department. He has served in various management positions of increasing responsibility, including leading teams on major projects in the business services, information technology, accounting and finance areas. Willis' departure is not the result of any disagreement with the company related to its financial statements, internal control over finan
Turnspire Capital Partners LLC ("Turnspire") announced today that an affiliate has completed the acquisition of Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), the former nutraceuticals business of Ashland Inc. (NYSE:ASH). Additionally, Turnspire Operating Partner Maurice Murphy has been appointed Executive Chairman, and Jeff Rogers has been appointed Interim Chief Executive Officer of Pharmachem. Pharmachem is a leading provider of proprietary nutrition ingredients and custom formulation services that supplies a broad portfolio of both active ingredients and formulation aids to nutritional product companies. The Company also offers custom formulation and contract manufactu
Pharmachem Innovations, LLC ("Pharmachem" or the "Company"), a leading provider of nutraceuticals products and solutions, today announced its launch as an independent company, following the acquisition of the Company from Ashland, Inc. (NYSE:ASH) by Turnspire Capital Partners LLC ("Turnspire"). Headquartered in Kearny, NJ, Pharmachem has a long history of working closely with customers around the world to develop and produce a wide range of specialized nutraceuticals. From its manufacturing facilities in New Jersey and Utah in the United States and Tamaulipas, Mexico, Pharmachem produces a wide range of proprietary and private labeled products used in many applications, including hydratio
WILMINGTON, Del., May 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) is announcing the appointment of Ashish K. Kulkarni to its Board of Directors. Kulkarni is the CEO of Kebotix, a startup company focused on commercializing artificial intelligence methods into new material commercialization. He is the former executive vice president and chief innovation officer, GAF, former chief technology and innovation officer, Avantor and former chief technology and innovation officer, Celanese Corporation. He will serve on the Board's Environmental, Health, Safety and Quality, and Compensation Committees, effective May 6, 2024. Prior to Celanese, Kulkarni held leadership positions at United Te
WILMINGTON, Del., April 15, 2024 (GLOBE NEWSWIRE) -- Effective today, Ashland Inc. (NYSE:ASH) has announced the appointment of Scott A. Tozier, strategic advisor to the CEO and former executive vice president and chief financial officer of Albemarle Corporation to its Board of Directors. Tozier will serve on the Board's Audit Committee and Environmental, Health, Safety and Quality Committee, each also effective April 15, 2024. Prior to Albemarle, Tozier held several leadership positions at Honeywell International, Inc. and served on the Board of Directors for Garrett Motion, Inc. Tozier is an experienced global executive with strong industry leadership in financial management, mergers and
WILMINGTON, Del., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) has announced the appointment of Sanat Chattopadhyay, executive vice president of Merck & Company (NYSE:MRK) to its Board of Directors. Chattopadhyay will serve on the Board's Environmental, Health, Safety, and Quality and Governance and Nominating Committees, effective November 13, 2023. Prior to Merck, Chattopadhyay held leadership positions at Wyeth Pharmaceuticals, Aventis, Hoechst Marion Roussel and Hoechst India. As previously announced, Jay V. Ihlenfeld who has served as a director since 2017, and Brendan M. Cummins, who joined the board in 2012 have decided not to stand for re-election at Ashland's Annua
WILMINGTON, Del., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced that its board of directors has approved the appointment of Robin Lampkin as senior vice president, general counsel and secretary. Lampkin joined Ashland in 1991 and has held various roles throughout her 32-year tenure including tort litigation and global environmental regulatory and remediation. As Ashland's chief compliance officer, she has deep corporate governance experience partnering with a variety of stakeholders on global regulatory compliance, training programs, policy administration and ethics investigations. Lampkin is a strategic advisor for global teams for product safety, sustainab
WILMINGTON, Del., June 26, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced the appointment of Sergio Pedreiro, former chief operating officer, Revlon, to its Board of Directors, effective July 1, 2023. Jay V. Ihlenfeld who has served as a director since 2017, and Brendan M. Cummins, who joined the board in 2012 have decided not to stand for re-election at Ashland's Annual Shareholders Meeting in January 2024. Ihlenfeld is the former senior vice president, 3M Company and member of the environmental, health, safety and quality committee and the governance and nominating committee. Cummins is the former chief executive officer of Ciba Specialty Chemicals and the chair of
WILMINGTON, Del., June 10, 2022 (GLOBE NEWSWIRE) -- Ashland Global Holdings Inc. (NYSE:ASH) today announced the appointment of two new directors to its Board as of July 1, 2022: Steve Bishop, former chief executive officer, Procter and Gamble (P&G) consumer health care, and Suzan Harrison, former president, Colgate-Palmolive global oral care. William Dempsey who has served as a director since 2016, and Ricky Sandler, who joined the board in 2020 have decided not to stand for re-election at Ashland's Annual Shareholders Meeting in January 2023. Dempsey is the former executive vice president, global pharmaceuticals, Abbott Laboratories and the current chair of the Board's governance and n
This live feed shows all institutional transactions in real time.
SC 13G - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13D/A - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13G - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13G/A - ASHLAND INC. (0001674862) (Subject)
SC 13D/A - ASHLAND GLOBAL HOLDINGS INC (0001674862) (Subject)
Live finance-specific insights
WILMINGTON, Del., May 05, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock which represents a 1.2 percent increase from the previous quarter. The dividend will be payable on June 15, 2026, to stockholders of record at the close of business on June 1, 2026. As of April 30, 2026, there were 45,788,007 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of co
Sales of $482 million, up one percent from the prior-year quarterIncome from continuing operations of $15 million, or $0.32 per diluted shareAdjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $42 million, or $0.91 per diluted shareNet income of $16 million, or $0.34 per diluted shareAdjusted EBITDA of $98 million, down nine percent from the prior-year quarter, primarily reflecting temporary operational impacts from the Calvert City startup delay, Hopewell productivity challenges, and weather-related disruptions in the second quarterCash flows provided by operating activities of $50 million; Ongoing Free Cash Flow2 of $29 millionUpdating full‑year fiscal
WILMINGTON, Del., April 15, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced plans to issue its second-quarter fiscal 2026 earnings release at approximately 5 p.m. ET on Tuesday, April 28, 2026. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Wednesday, April 29. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chair, and chief executive officerWilliam Whitaker, senior vice president, and chief fi
Sales of $386 million, down five percent from the prior-year quarterPreviously announced Avoca divestiture reduced overall sales by approximately $10 million or two percent versus the prior-year quarter; excluding the Avoca divestiture, sales declined three percentLoss from continuing operations of $14 million, or $(0.30) per diluted shareAdjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $12 million, or $0.26 per diluted shareNet loss of $12 million, or $(0.26) per diluted shareAdjusted EBITDA of $58 million, down five percent from the prior-year quarter, with the Avoca divestiture contributing to a two percent or $1 million decline; excluding the Avoca
WILMINGTON, Del., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced plans to issue its first-quarter fiscal 2026 earnings release at approximately 5 p.m. ET on Monday, February 2, 2026. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Tuesday, February 3. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chair, and chief executive officerWilliam Whitaker, senior vice president, and chief fina
WILMINGTON, Del., Jan. 19, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock. The dividend will be payable on March 15, 2026, to stockholders of record at the close of business on March 1, 2026. As of December 31, 2025, there were 45,762,391 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coat
WILMINGTON, Del., Nov. 19, 2025 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE:ASH) has declared a quarterly cash dividend of $0.415 cents per share on the company's common stock. The dividend will be payable on December 15, 2025, to stockholders of record at the close of business on December 1, 2025. As of October 31, 2025, there were 45,718,113 shares of Ashland common stock outstanding. About Ashland Ashland Inc. (NYSE:ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectur
Sales of $478 million, down eight percent from the prior-year quarterPreviously announced carboxymethylcellulose (CMC), methylcellulose (MC), Nutraceuticals and Avoca portfolio optimization initiatives (collectively, Portfolio Optimization) reduced overall sales by approximately $38 million or seven percent versus the prior-year quarter. Excluding these initiatives, sales declined one percentIncome from continuing operations of $33 million, or $0.73 per diluted shareAdjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $50 million, or $1.08 per diluted shareNet income of $32 million, or $0.71 per diluted shareAdjusted EBITDA of $119 million, down four p
WILMINGTON, Del., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) has changed the start time of its fourth-quarter fiscal 2025 earnings webcast being held on Wednesday, November 5, 2025. The event will now begin at 10:00 a.m. ET instead of 9:00 a.m. ET. Attendees that have previously registered do not need to register again. The company's live webcast with securities analysts will include an executive summary and detailed remarks. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. To access the call by phone, please go to this registration link and you will be provided with dial in detail
WILMINGTON, Del., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) today announced plans to issue its fourth-quarter fiscal 2025 earnings release at approximately 5 p.m. ET on Tuesday, November 4, 2025. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 9 a.m. ET on Wednesday, November 5. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com. Among those participating in the webcast presentation will be: Guillermo Novo, chair, and chief executive officerWilliam Whitaker, senior vice president, and chief